Home|
Japanese Drug Company Bids for U.S. Biotech Firm Japan’s Takeda Pharmaceutical has agreed to pay $8.8 billion in cash for Millennium Pharmaceuticals, one of the earliest American genomics companies. Home > Rss Directory > Business > NY Time |
|
MacroGenics Buys Drug Developer to Bolster Cancer Work The orphaned Raven has found a parent. MacroGenics, a Rockville biotech, announced yesterday that it bought cancer drug developer Raven Biotechnologies of South San Francisco, Calif. Until last March, it looked like another biotech firm would be adopting Raven. VaxGen, also of South San Francisco... Home > Rss Directory > Technology > WashingtonPost |
|
Vintage Japanese Robots Storm Sci-Fi Museum : Though made for children, Japanese toy robots can catch the eye of even the most discriminating adults. Iconic graphic designer Tom Geismar, whose firm Chermayeff & Geismar has created memorable logos for Mobil, PBS and other U.S. institutions, has been collecting the shiny bots Home > Rss Directory > General > Wired News |
|
Vintage Japanese Robots Storm Sci-Fi Museum : Though made for children, Japanese toy robots can catch the eye of even the most discriminating adults. Iconic graphic designer Tom Geismar, whose firm Chermayeff & Geismar has created memorable logos for Mobil, PBS and other U.S. institutions, has been collecting the shiny bots Home > Rss Directory > Technology > Wired News |
|
Japanese Drug Maker to Pay $1.1 Billion for U.S. Rival Shionogi & Company, the Japanese drug maker, plans to buy an American rival, Sciele Pharma for $1.1 billion. Home > Rss Directory > Business > NY Time |
|
HGS Reports Early Positive Results for Hepatitis C Drug Human Genome Sciences, a Washington area biotech company that in 16 years has yet to bring a commercial treatment to market, said yesterday that results were positive for the first of two late-stage clinical trials of its hepatitis C drug. Home > Rss Directory > Technology > WashingtonPost |
|
Experimental Drug Makes the Immune System Revolt Against Cancer A biotech company announces its experimental drug is producing impressive results in seven Non-Hodgkin's Lymphoma patients. All of them have had at least three conventional treatments fail them, but they show signs of recovery after receiving doses of a two-headed antibody. Home > Rss Directory > General > Wired News |
|
Experimental Drug Makes the Immune System Revolt Against Cancer A biotech company announces its experimental drug is producing impressive results in seven Non-Hodgkin's Lymphoma patients. All of them have had at least three conventional treatments fail them, but they show signs of recovery after receiving doses of a two-headed antibody. Home > Rss Directory > Technology > Wired News |
|
Drug Companies Get Healthy, but at Whose Expense? News from Portfolio.com Also on Portfolio Esquire, E-Ink: Future of Print? Hollywood's Sudden Cash Crunch Even Conservatives Hate Michael Savage Subscribe to Portfolio magazine Trevor Foltz was six months old last fall, Home > Rss Directory > General > Wired News |
|
Drug Companies Get Healthy, but at Whose Expense? News from Portfolio.com Also on Portfolio Esquire, E-Ink: Future of Print? Hollywood's Sudden Cash Crunch Even Conservatives Hate Michael Savage Subscribe to Portfolio magazine Trevor Foltz was six months old last fall, Home > Rss Directory > Technology > Wired News |
|
Meet Hiroyuki Nishimura, the Bad Boy of the Japanese Internet I'm sitting in a sterile white conference room waiting for Hiroyuki Nishimura. Japan is a nation where the 3:17 train arrives every day at 3:17 — not 3:16 or 3:18 — and Nishimura is 45 minutes late. The PR assistant who painstakingly coordinated our interview, a typical salarym Home > Rss Directory > Business > Wired News |
|
Japanese to Buy U.S. Drug Maker Shionogi & Company plans to buy an American rival, Sciele Pharma, for $1.1 billion, the fourth big overseas deals in nine months by a Japanese company eager to expand overseas. Home > Rss Directory > Business > NY Time |
|
German Health Care Company Buying Intravenous Drug Firm The German health care company Fresenius said it had agreed to buy the American generic drug maker APP Pharmaceuticals for $3.7 billion. Home > Rss Directory > Business > NY Time |
|
A Brief Tour of the Japanese Web I'm sitting in a smoky room on the second floor of a Tully's Coffee in Western Tokyo, looking over the shoulder of Ichiroo Kiyota as he types on his laptop. Kiyota, an executive at Six Apart Japan, is showing me around some of the most popular — and useless — Web apps in the countr Home > Rss Directory > Business > Wired News |
|
Global Biotech Drug Sales Hit $75 Billion In 2007 (AHN) (AHN) - The global sales of biotech drugs went up by 12.5 percent in 2007 to over $75 billion. - Wed, 18 Jun 2008 11:39:34 GMT (AHN) Home > Rss Directory > Business > AllHeadline |
|
Eli Lilly bids $6.5 billion for ImClone
(Reuters) Reuters - Eli Lilly and Co has agreed to acquire ImClone Systems Inc for $6.5 billion, outbidding Bristol-Myers Squibb Co and potentially bringing to a close one of the most colorful corporate sagas in biotech history. Home > Rss Directory > General > Yahoo News |
|
700MHz auction update: High bids total $3.2 billion The high bids totalled $3.2 billion in the U.S. Federal Communications Commission's auction of wireless spectrum licenses in the 700MHz band after three rounds and a day and a half of bidding.That figure is fa Home > Rss Directory > Technology > InfoWorld |
|
EA bids for Grand Theft Auto firm Electronic Arts goes public with its unsolicited offer for Grand Theft Auto firm Take-Two Interactive Software. Home > Rss Directory > Technology > BBC |
|
Japanese browser maker taking on IE, Firefox A Japanese software company is stepping up international promotion of its Web browser in the hope of carving out a 5 percent share over the next few years of a market dominated by Internet Explorer and Firefox.T Home > Rss Directory > Technology > InfoWorld |
|
Bids Total $2.78 Billion in Opening Day of Auction for Airwaves - New York Times Digitaltrends.comBids Total $2.78 Billion in Opening Day of Auction for AirwavesNew York Times - 1 hour agoBy REUTERS WASHINGTON (Reuters) - Bidders put up a total of almost $2.78 billion on Thursday in the opening rounds of the Federal Communications Commissionâ€℠Home > Rss Directory > General > Google News |